Edition:
India

OncoSec Medical Inc (ONCS.OQ)

ONCS.OQ on NASDAQ Stock Exchange Capital Market

1.35USD
27 Mar 2020
Change (% chg)

$0.10 (+8.00%)
Prev Close
$1.25
Open
$1.27
Day's High
$1.35
Day's Low
$1.24
Volume
5,964
Avg. Vol
19,108
52-wk High
$7.40
52-wk Low
$1.06

Latest Key Developments (Source: Significant Developments)

OncoSec Appoints Robert J. Delaversano As Principal Accounting Officer And Controller
Wednesday, 22 Jan 2020 

Jan 21 (Reuters) - OncoSec Medical Inc ::ONCOSEC ANNOUNCES THE APPOINTMENT OF ROBERT J. DELAVERSANO, C.P.A, AS PRINCIPAL ACCOUNTING OFFICER AND CONTROLLER.ONCOSEC MEDICAL INC - SARA M. BONSTEIN WILL BE STEPPING DOWN FROM HER ROLES AS CHIEF FINANCIAL OFFICER.  Full Article

Oncosec Announces 1-For-10 Reverse Stock Split
Monday, 20 May 2019 

May 20 (Reuters) - OncoSec Medical Inc ::ONCOSEC ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT.ONCOSEC MEDICAL INC - REVERSE STOCK SPLIT WILL BECOME EFFECTIVE AT 5:00 PM EASTERN TIME ON MAY 20, 2019.  Full Article

Oncosec Medical Enters Into Common Stock Purchase Agreement With Aspire Capital Fund
Saturday, 30 Mar 2019 

March 29 (Reuters) - OncoSec Medical Inc ::ONCOSEC MEDICAL INC SAYS ON MARCH 29, CO ENTERED INTO COMMON STOCK PURCHASE AGREEMENT WITH ASPIRE CAPITAL FUND - SEC FILING.ONCOSEC MEDICAL INC SAYS AS PER AGREEMENT, ASPIRE CAPITAL COMMITTED TO PURCHASE UP TO AGGREGATE OF $20 MILLION OF SHARES OF CO'S COMMON STOCK.  Full Article

BRIEF-OncoSec Announces Publication Of Positive Tavo Monotherapy Results In Metastatic Melanoma Patients In Annals Of Oncology

* ONCOSEC ANNOUNCES PUBLICATION OF POSITIVE TAVO™ MONOTHERAPY RESULTS IN METASTATIC MELANOMA PATIENTS IN ANNALS OF ONCOLOGY Source text for Eikon: Further company coverage: